Treatment of bipolar mania with atypical antipsychotics

References

• American Psychiatric Association. Practice Guidelines for the Treatment of Patients with Bipolar Disorder (Revision). Am. J. Psychiatry 159(Suppl.), 1–50 (2002).
   Google Scholar
• Scarna A, Gijsman HJ, McTavish SF, Harmer CJ, Cowen PJ, Goodwin GM. Effects of a branched-chain amino acid drink in mania. Br. J. Psychiatry 182, 210–213 (2003).
   Google Scholar
• Calabrese JR, Kimmel SE, Woyshville MJ et al. Clozapine for treatment-refractory mania. Am. J. Psychiatry 153, 759–764 (1996).
   Google Scholar
• Jones AM, Huizar K. Quetiapine monotherapy for acute mania associated with bipolar disorder (STAMP 1 and STAMP 2). Bipolar Disord. 5(Suppl. 1), 57 (2003) (Abstract P95).
   Google Scholar
• Tohen M, Sanger TM, McElroy SL et al. Olanzapine versus placebo in the treatment of acute mania. Am. J. Psychiatry 156, 702–709 (1999).
   Google Scholar
• Hirschfeld RM, Keck PE Jr, Kramer M et al. Rapid antimanic effect of risperidone monotherapy: a 3-week multicenter, double-blind, placebo-controlled trial. Am. J. Psychiatry 161, 1057–1065 (2004).
   Google Scholar
• Keck PE Jr, Versiani M, Potkin S et al. Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomised trial. Am. J. Psychiatry 160, 741–748 (2003).
   Google Scholar
• Keck PE Jr, Marcus R, Tourkodimitris S et al. A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania. Am. J. Psychiatry 160, 1651–1658 (2003).
   Google Scholar
• Segal J, Berk M, Brook S. Risperidone compared with both lithium and haloperidol. Poster presented at the 156th Annual Meeting of the American Psychiatric Association. San Francisco, CA, USA. 17–22 May (2003).
   Google Scholar
• Tohen M, Jacobs TG, Grundy SL et al. Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. Arch. Genet. Psychiatry 57, 841–849 (2000).
   Google Scholar
• Tohen M, Baker RW, Altshuler LL et al. Olanzapine versus divalproex in the treatment of acute mania. Am. J. Psychiatry 159, 1011–1017 (2002).
   Google Scholar
• Berk M, Ichim L, Brook S. Olanzapine compared to lithium in mania: a double-blind, randomized controlled trial. Int. Clin. Psychopharmacol. 14, 339–343 (1999).
   Google Scholar
• Segal J, Berk M, Brook S. Risperidone compared with both lithium and haloperidol in mania: a double-blind randomised controlled trial. Clin. Neuropsychopharmacol. 21, 176–180 (1998).
   Google Scholar
• Sajatovic M, Brescan DW, Perez DE et al. Quetiapine alone and added to a mood stabilizer for serious mood disorders. J. Clin. Psychiatry 62, 728–732 (2001).
   Google Scholar
• Brecher M, Huizar K. Quetiapine vs. placebo for acute mania associated with bipolar disorder (STAMP 1). Bipolar Disord. 5(Suppl. 1), 35 (2003) (Abstract P27).
   Google Scholar
• Paulsson B, Huizar K. Quetiapine monotherapy vs. placebo for acute bipolar mania (STAMP 2). Bipolar Disord. 5(Suppl. 1), 74 (2003) (Abstract P153).
   Google Scholar
• Segal S, Riesenberg RA, Ice K, English P. Ziprasidone in mania: a 21-day, randomised, double-blind, placebo-controlled trial. Presented at the 16th European College of Neuropsychopharmacology Congress. Prague, Czech Republic. 20–24th September (2003).
   Google Scholar
• Baker RW et al. 156th Annual Meeting of the American Psychiatric Association. San Francisco, CA, USA. 17–22 May (2003).
   Google Scholar
• Yatham LN, Paulsson B, Mullen J, Vågerö M. Quetiapine versus placebo in combination with lithium or divalproex for the treatment of bipolar mania. J. Clin. Psychopharmacol. (2004) (In Press).
   Google Scholar
• Tohen M, Chengappa KN, Suppes T et al. Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium therapy. Arch. Genet. Psychiatry 59, 62–69 (2002).
   Google Scholar
• Sachs GS, Grossman F, Ghaemi SN et al. Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety. Am. J. Psychiatry 159, 1146–1154 (2002).
   Google Scholar
• Yatham LN, Grossman F, Augustyns I et al. Mood stabilisers plus risperidone or placebo in the treatment of acute mania: an international, double-blind, randomised, controlled trial. Br. J. Psychiatry 182, 141–147 (2003).
   Google Scholar
• Weisler R, Dunn J, English P. Ziprasidone in adjunctive treatment of acute bipolar mania: randomized, double-blind, placebo-controlled trial. Poster presented at the 16th European College of Neuropsychopharmacology Congress, Prague, Czech Republic, 20–24 September (2003).
   Google Scholar
• Delbello MP, Schwiers ML, Rosenberg HL, Strakowski SM. A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania. J. Am. Acad. Child. Adolesc. Psychiatry 41, 1216–1223 (2002).
   Google Scholar
• Sanger TM, Grundy SL, Gibson PJ et al. Long-term olanzapine therapy in the treatment of bipolar I disorder: an open-label continuation phase study. J. Clin. Psychiatry 62, 273–281 (2001).
   Google Scholar
• Tohen M, Ketter TA, Zarate CA et al. Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study. Am. J. Psychiatry 160, 1263–1271 (2003).
   Google Scholar
• Chengappa KN, Baker RW, Shao L et al. Rates of response, euthymia and remission in two placebo-controlled olanzapine trials for bipolar mania. Bipolar Disord. 5, 1–5 (2003).
   Google Scholar
• Suppes T, Webb A, Paul B et al. Clinical outcome in a randomised 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of mania. Am. J. Psychiatry 156, 1164–1169 (1999).
   Google Scholar
• Jibson MD, Tandon R. New atypical antipsychotic medications. J. Psychiatry Res. 32, 215–228 (1998).
   Google Scholar
• Tandon R, Jibson MD. Efficacy of newer generation antipsychotics in the treatment of schizophrenia. Psychoneuroendocrinology 28(Suppl. 1), 9–26 (2003).
   Google Scholar
• Goodnick PJ, Jerry JM. Aripiprazole: profile on efficacy and safety. Expert Opin. Pharmacother. 3, 1773–1781 (2002).
   Google Scholar
• Whitworth AB, Fleischhacker WW. Adverse effects of antipsychotic drugs. Int. Clin. Psychopharmacol. 9(Suppl. 5), 21–27 (1995).
   Google Scholar
• Zarate CA Jr. Antipsychotic drug side effect issues in bipolar mania patients. J. Clin. Psychiatry 61(Suppl. 8), 52–61 (2000).
   Google Scholar
• Tandon R, Jibson MD. Extrapyramidal side effects of antipsychotic treatment: scope of the problem and impact on outcome. Ann. Clin. Psychiatry 14, 123–129 (2002).
   Google Scholar
• Stimmel GL, Gutierrez MA, Lee V. Ziprasidone: an atypical antipsychotic drug for the treatment of schizophrenia. Clin. Ther. 24, 21–37 (2002).
   Google Scholar
• Khanna S, Vieta E, Lyons B et al. Risperidone monotherapy in acute bipolar mania. Bipolar Disord. 5(Suppl. 1), 60 (2003) (Abstract P108).
   Google Scholar
• Lemmens P, Brecher M, Van Baelen B. A combined analysis of double-blind studies with risperidone vs. placebo and other antipsychotic agents: factors associated with extrapyramidal symptoms. Acta Psychiatry Scand. 99, 160–170 (1999).
   Google Scholar
• Owens DGC. Extrapyramidal side effects and tolerability of risperidone: a review. J. Clin. Psychiatry 55(Suppl. 5), 29–35 (1994).
   Google Scholar
• Marcus R, Saha A, Jody D, Tourkodimitris S, Archibald D, Iwamoto T. Aripiprazole versus placebo in acute mania. J. Eur. Coll. Neuropsychopharmacol. 12(Suppl. 3), S289 (2002) (Abstract P.2.081).
   Google Scholar
• Kane JM. Tardive dyskinesia in affective disorders. J. Clin. Psychiatry 60(Suppl. 5), 43–47 (1999).
   Google Scholar
• Calabrese JR, Kasper S, Johnson G et al. International Consensus Group on Bipolar I Depression Treatment Guidelines. J. Clin. Psychiatry 65, 569–579 (2004).
   Google Scholar
• American Diabetes Association; American Psychiatric Association; American Association of Clinical Endocrinologists; North American Association for the Study of Obesity. Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care 27, 596–601 (2004).
   Google Scholar
• Phan KL, Taylor SF. Clozapine-associated cardiomyopathy. Psychosomatics 43, 248 (2002).
   Google Scholar
• Tanner MA, Culling W. Clozapine associated dilated cardiomyopathy. Postgrad. Med. J. 79, 412–413 (2003).
   Google Scholar
• Mullen B, Brar JS, Vagnucci AH, Ganguli R. Frequency of sexual dysfunction in patients with schizophrenia on haloperidol, clozapine or risperidone. Schizophr. Res. 48, 155–158 (2001).
   Google Scholar
• Suppes T, Leverich GS, Keck PE et al. The Stanley Foundation Bipolar Treatment Outcome Network. II. Demographics and illness characteristics of the first 261 patients. J. Affect. Disord. 67, 45–59 (2001).
   Google Scholar